The Spectrum Brief
Autism research, in plain language
← Back to the feed

Diagnosis & ScreeningResearch

Emerging Biomarker Research May Expand Options for Autism Recognition

From eye-tracking to microbiome analysis, new approaches aim to identify autism traits earlier — though validation and accessibility challenges remain.

By The Spectrum Brief newsroom · 2 hours ago·Based on peer-reviewed research
Share

Expanding Identification Approaches

Current autism identification typically occurs between ages 2-4 through behavioral observation, though recognition often comes later for girls and marginalized groups. Emerging research explores whether biological markers might help identify autism-related traits earlier. A 2024 study in Nature found certain urinary metabolites associated with gut bacteria differences in some autistic individuals, while eye-tracking research published in JAMA Network Open (May 2024) showed gaze patterns could help distinguish autistic children as young as 18 months.

Developing Technologies

Researchers are investigating multiple approaches:

A 2025 Frontiers in Psychiatry review notes that personalized approaches beginning before age 3 may help with communication development.
  • Eye-tracking: Studies like those summarized in Contemporary Pediatrics (2026) suggest gaze patterns may offer early indicators
  • Microbiome analysis: A Hong Kong team is preparing a pilot study of an AI-assisted stool test (CUHK announcement), though its claimed 95% accuracy lacks peer-reviewed verification
  • Digital phenotyping: Research in Nature (2023) found movement patterns from wearable devices might help identify autism-related traits

Potential Benefits of Earlier Recognition

When support aligns with an individual's needs early in development, research suggests it can improve quality of life. A 2025 Frontiers in Psychiatry review notes that personalized approaches beginning before age 3 may help with communication development. However, experts emphasize that autism manifests differently across individuals, and support should focus on enabling thriving rather than 'normalization'.

Key Considerations

  • No biomarker test is currently validated for standalone autism identification
  • Autism's neurodiversity means single biomarkers are unlikely to capture its full spectrum
  • Gut microbiome findings may reflect associated traits rather than autism itself (PMC review)
  • Digital phenotyping requires careful privacy protections
  • Earlier recognition must be paired with accessible, neurodiversity-affirming support
#biomarkers#earlydiagnosis#neuroscience#pediatrics#AI

Common questions

Share

Behind the brief

Adversarial editorial review

Approved73/100 consensus· 2 rounds

Open thread

Discussion

0 comments · The editorial board joins in. Be kind and cite sources where you can.

Loading comments…